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R
ecent developments in 
environmental epidemiology 
offer the promise of 
strengthening human health 
protection. Regulatory agencies 
responsible for protecting human 
health from environmental hazards 
assess data on relationships between 
exposure levels and adverse 
health effects to develop limits for 
contaminant levels in air, water, 
food, soil, house dust, and consumer 
products. Most regulatory agencies 
assume that there is no safe level 
of exposure to carcinogens and 
use linear dose-response models to 
estimate human health risks at low 
exposure levels. In contrast, regulators 
usually assume that a threshold, 
or “safe,” exposure level exists for 
noncarcinogens. 
Risk Assessment
In conducting risk assessments 
to characterize potential adverse 
health effects of human exposures to 
environmental hazards [1], regulators 
depend on experimental animal 
studies in the absence of adequate 
epidemiologic data. These studies 
are critical to uncover health effects 
before human exposure occurs (e.g., 
premarket testing of a new chemical) 
whereas epidemiologic studies can 
be used to directly evaluate health 
effects among exposed persons. The 
difﬁ  culty of directly measuring health 
risks at very low exposure levels can 
be an important limitation of both 
epidemiologic and toxicologic studies. 
Sources of uncertainty in 
conventional animal studies include: 
(1) the much shorter exposure 
period compared to humans, (2) 
testing is often limited to adult (but 
not pregnant, newborn, or sexually 
immature) animals, (3) use of 
genetically homogeneous animals (with 
loss of the ability to detect potentially 
heightened risks among genetically 
diverse subgroups, such as exist in 
human populations), (4) the use 
of very high doses of test chemicals 
(e.g., administration of high doses 
of a teratogenic toxicant to pregnant 
animals may cause early pregnancy 
loss before birth defects can be readily 
observed), (5) small numbers of test 
animals, and (6) the need to extrapolate 
across species to humans [2]. 
For instance, neurotoxic effects 
of prenatal or early-life exposure to 
lead, polychlorinated biphenyls, and 
methylmercury in humans occur at 
intake levels about three orders of 
magnitude lower than those predicted 
from rodent data [3]. The role of 
potential biases and crude exposure 
indices in producing uncertainties 
in epidemiologic studies has been 
reduced, to some degree, by the 
increasing use of improved study 
methodologies, e.g., the use of 
exposure and susceptibility biomarkers. 
The following case studies for four 
of the most widespread and extensively 
studied environmental hazards show 
that (1) there is no apparent threshold 
for health risks with dose-response 
relationships over exposure ranges far 
below those generally used in animal 
studies, and, in some cases, (2) there 
are higher risks per unit of exposure 
dose at low exposure levels.
Case Studies
Lead. Lead is a potent neurotoxin 
capable of causing severe childhood 
brain damage at blood lead levels only 
2- to 3-fold higher than those that 
cause no overt symptoms. Overt lead 
poisoning has been recognized for 
centuries, but there was no convincing 
evidence of IQ deﬁ  cits at relatively 
low-level lead exposure until 1979 [4]. 
Noting the lack of a lead exposure 
threshold for impaired cognitive 
function and heme synthesis, the 
Environmental Protection Agency 
has not speciﬁ  ed a safe exposure 
level. The United States Centers for 
Disease Control and Prevention do not 
recommend public health or medical 
actions for children unless their blood 
lead level exceeds 0.48 µM (10 µg⁄dl), 
a level about 100-fold higher than 
that estimated for pre–Industrial-Age 
children [5]. Epidemiologic studies 
of children in several countries found 
inverse relationships between IQ 
and blood lead levels over a range 
extending below 0.48 µM, with no 
evidence of a threshold [6].
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In a recent study of over 4,000 
children, scores on four cognitive test 
subscales (math, reading, block design, 
digit span) were inversely associated 
with current blood lead levels, even in 
analyses restricted to those with blood 
lead levels less than 0.48 µM (<10 
µg⁄dl) [7]. The inverse relationship for 
math and reading scores persisted in 
the subgroup with blood lead levels less 
than 0.24 µM (<5 µg⁄dl), and reading 
deﬁ  cits per unit blood lead increment 
were greater among those with lower 
blood lead levels. 
Similarly, another birth cohort study 
found an inverse relationship between 
IQ at age 10 to 12 years and quartiles 
of tibial bone lead concentration with 
the greatest IQ decrement occurring 
between the lower two quartiles [8]. 
Two longitudinal US birth cohort 
studies found inverse relationships 
between full-scale IQ and blood lead 
among children whose blood lead level 
since birth never exceeded 0.48 µM 
[9,10]. In a pooled analysis of seven 
of the eight prospective longitudinal 
studies, the investigators reported that 
the average IQ deﬁ  cit associated with 
an increase in concurrent blood lead 
concentration from less than 0.048 µM 
to 0.48 µM was about 3-fold higher than 
the average IQ deﬁ  cit associated with 
an increase in concurrent blood lead 
concentration from 0.48 µM to 0.96 µM 
[11]. The latter report included a log-
linear model for IQ versus concurrent 
blood lead concentration, including 
adjustment for HOME Score (Home 
Observation for Measurement of the 
Environment, a standardized measure 
of the home environment), maternal 
education, maternal IQ, and birth 
weight, that clearly showed the steeper 
dose-response relationship at low blood 
lead levels (Figure 1). 
Tobacco smoke. There is convincing 
epidemiologic evidence that prenatal 
maternal active smoking impairs 
fetal growth. A US prospective study 
demonstrated an inverse nonlinear 
relationship between term birth weight 
and third-trimester smoking intensity, 
with larger birth weight decrements at 
low maternal smoking intensities [12]. 
It now appears that even low-level 
exposure to environmental tobacco 
smoke (ETS), or “passive smoking,” 
can reduce fetal growth. In a Finnish 
study of nonsmoking women, the risk 
of preterm birth was dose-related to 
self-reported prenatal maternal ETS 
exposure intensity and maternal hair 
nicotine levels [13]. Glutathione-
S-transferase (GST) enzymes 
detoxify many chemicals, including 
polycyclic aromatic hydrocarbons 
and certain other toxicants present 
in tobacco smoke. A Korean study 
of nonsmoking women found that 
combined maternal ETS exposure 
and null polymorphisms of two GST 
genes involved in tobacco smoke 
metabolism (GSTT1 and GSTM1) 
were associated with birth weight 
deﬁ  cits [14]. A US study of over 4,000 
children age 6 to16 years found inverse 
dose-response relationships between 
serum cotinine (the major metabolite 
of nicotine) and scores on reading, 
math, and visuospatial reasoning 
independent of several potential 
confounders [15]. Importantly, the 
dose-response relationship between 
reading scores and serum cotinine was 
stronger among children with cotinine 
concentrations below 0.5 ng⁄ml 
compared to those with higher levels. 
Radon. An expert committee 
recently concluded that the most 
plausible relationships between low-
level ionizing radiation and mutations, 
chromosome aberrations, and cancer 
are linear, with no threshold [16]. 
The high radon levels in the air of 
some underground mines cause lung 
cancer among occupationally exposed 
men, the risk being a linear function 
of cumulative radiation dose [17]. A 
pooled analysis of eight epidemiologic 
studies of underground miners showed 
that the excess risk of lung cancer per 
unit of cumulative radon exposure 
was greater at lower exposure levels 
[18]. Among men with the same 
cumulative radon exposure, therefore, 
prolonged exposure at low levels is 
more hazardous than shorter exposures 
at higher levels. 
Indoor air radon levels vary widely 
in homes and other buildings. 
Average cumulative radon doses from 
lifetime residential exposures are 
about 10-fold lower than those among 
exposed miners. Despite the relatively 
low average radon levels in homes, 
combined analysis of 17 epidemiologic 
studies showed that persons with time-
weighted average residential radon 
exposures of 150 Bq⁄m3 (the current 
level above which the Environmental 
Protection Agency recommends actions 
to conﬁ  rm radon levels and sources 
and the need for remedial measures 
such as ventilation) had a 24% (95% 
CI 11%–38%) increased lung cancer 
risk [19]. Thus, directly measured lung 
cancer risk at relatively low radon levels 
in the general population is consistent 
with an estimate based on linear 
extrapolations of risks for miners with 
much higher average exposures [20]. 
DOI: 10.1371⁄journal.pmed.0020350.g001
Figure 1. Log-Linear Model for IQ Versus Concurrent Blood Lead Concentration, Adjusted for 
HOME Score, Maternal Education, Maternal IQ, and Birth Weight
The mean IQ (95% conﬁ  dence intervals) for the intervals <5 µ⁄dl, 5–10 µ⁄dl, 10–15 µ⁄dl, 15–20 µ⁄dl, 
and >20 µ⁄dl are shown.
(Figure by authors, adapted from [11]).
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Chlorination disinfection by-products 
in drinking water. During disinfection 
of drinking water, chlorine reacts 
with naturally occurring organic 
material and produces many by-
products of disinfection, including 
the trihalomethanes (THMs) 
chloroform, bromodichloromethane, 
dibromochloromethane, and 
bromoform, that are known animal 
carcinogens. Based on a risk assessment 
of kidney tumors in rats chronically 
exposed to high chloroform doses, 
Health Canada concluded that the 
human lifetime cancer risk associated 
with drinking water containing THMs 
at 100 µg⁄l (the current Canadian 
THM drinking water guideline) would 
be negligible [21]. However, a recent 
pooled analysis of six epidemiologic 
studies of human bladder cancer with 
over 8,000 subjects showed that men 
exposed to THM levels above 1 µg⁄l 
had a 24% increased bladder cancer 
risk compared to less exposed men, 
representing an excess lifetime bladder 
cancer risk of about seven per 1,000 
[22]. This risk is much higher than 
those usually designated as negligible 
(regulatory agencies have variably 
deﬁ  ned negligible risk as a lifetime 
excess risk of 10−6 to 10−5). Thus, a 
risk assessment of THMs based on 
carcinogenicity of chloroform in 
animals may greatly underestimate 
human cancer risk. 
Conclusion
In contrast with animal studies, 
epidemiologic studies can be used to 
assess health risks at exposure levels 
prevalent in human populations. 
Findings from some of the most 
thoroughly studied and widely dispersed 
environmental contaminants indicate 
that there is no apparent safe exposure 
level. Indeed, in some cases, there 
are greater risks for a given exposure 
at the relatively low exposure levels 
most prevalent in human populations. 
Environmental chemicals should be 
thoroughly evaluated for toxicity before 
they are marketed [23], but when 
available, epidemiologic data should 
preferentially be used to develop 
environmental standards and to assess 
the adequacy of existing standards based 
on experimental animal studies.
The public depends on decision 
makers, scientists, and regulators 
to restrict exposure to widespread 
toxins that have known or suspected 
serious potential health effects. We 
hold that risk assessments should not 
assume thresholds for noncarcinogens 
as well as carcinogens, especially for 
toxins shown in epidemiologic data 
to exhibit no apparent threshold 
and those not yet adequately tested 
for developmental toxicity. The four 
major toxins reviewed here are widely 
dispersed in the environment and 
emerging evidence indicates that 
exposures must be virtually eliminated 
to protect human health. It would be 
imprudent to assume that there are not 
other widely distributed environmental 
toxins or chemicals with the potential 
to cause adverse human health effects 
at exposure levels currently considered 
to be “low.”  
References
1.   National Academy of Sciences (1983) Risk 
assessment in the federal government: 
Managing the process. Available: http:⁄⁄www.
nap.edu⁄openbook⁄POD115⁄html⁄. Accessed 
3 September 2005.
2.   National Academy of Sciences (2000) Scientiﬁ  c 
frontiers in developmental toxicology and risk 
assessment. Washington (District of Columbia): 
National Academy Press. 354 p.
3.   Rice DC, Evangelista de Duffard AM, Duffard 
R, Iregren A, Satoh H, et al. (1996) Lessons 
for neurotoxicology from selected model 
compounds: SGOMSEC joint report. Environ 
Health Perspect 104(Suppl 2): S205–S215.
4.   Needleman HL, Gunnoe C, Leviton A, Reed R, 
Peresie H, et al. (1979) Deﬁ  cits in psychologic 
and classroom performance of children with 
elevated dentine lead levels. N Engl J Med 300: 
689–695.
5.   Mushak P (1993) New directions in the 
toxicokinetics of human lead exposure. 
Neurotoxicology 14: 29–42.
6.   Schwartz J (1994) Low-level lead exposure and 
children’s IQ: A meta-analysis and search for a 
threshold. Environ Res 65: 42–55.
7.   Lanphear BP, Dietrich K, Auinger P, Cox C 
(2000) Cognitive deﬁ  cits associated with blood 
lead concentrations <10 microg⁄dL in US 
children and adolescents. Public Health Rep 
115: 521–529.
8.   Wasserman GA, Factor-Litvak P, Liu X, Todd 
AC, Kline JK, et al. (2003) The relationship 
between blood lead, bone lead and child 
intelligence. Neuropsychol Dev Cogn C Child 
Neuropsychol 9: 22–34.
9.   Canﬁ  eld RL, Henderson CR Jr, Cory-Slechta 
DA, Cox C, Jusko TA, et al. (2003) Intellectual 
impairment in children with blood lead 
concentrations below 10 microg per deciliter. 
N Engl J Med 348: 1517–1526.
10. Bellinger DC, Needleman HL (2003) 
Intellectual impairment and blood lead levels. 
N Engl J Med 349: 500–502.
11. Lanphear BP, Hornung R, Khoury J, Yolton 
K, Baghurst P, et al. (2005) Low-level 
environmental lead exposure and children’s 
intellectual function: An international pooled 
analysis. Environ Health Perspect 113: 894–899.
12. England LJ, Kendrick JS, Gargiullo PM, 
Zahniser SC, Hannon WH (2001) Measures of 
maternal tobacco exposure and infant birth 
weight at term. Am J Epidemiol 153: 954–960.
13. Jaakkola JJ, Jaakkola N, Zahlsen K (2001) Fetal 
growth and length of gestation in relation to 
prenatal exposure to environmental tobacco 
smoke assessed by hair nicotine concentration. 
Environ Health Perspect 109: 557–561.
14. Hong YC, Lee KH, Son BK, Ha EH, Moon HS, 
et al. (2003) Effects of the GSTM1 and GSTT1 
polymorphisms on the relationship between 
maternal exposure to environmental tobacco 
smoke and neonatal birth weight. J Occup 
Environ Med 45: 492–498.
15. Yolton K, Dietrich K, Auinger P, Lanphear BP, 
Hornung R (2005) Exposure to environmental 
tobacco smoke and cognitive abilities among 
U.S. children and adolescents. Environ Health 
Perspect 113: 98–103.
16. National Council on Radiation Protection and 
Measurements (2001) Evaluation of the linear-
nonthreshold dose-response model for ionizing 
radiation. Bethesda (Maryland): National 
Council on Radiation Protection and Medicine. 
Report nr 136. 263 p. 
17. Lubin JH, Boice JD, Edling C, Hornung 
RW, Howe GR, et al. (1995) Lung cancer in 
radon-exposed miners and estimation of risk 
from indoor exposure. J Natl Cancer Inst 87: 
817–827.
18. Hornung RW ( 2001) Health effects in 
underground uranium miners. Occup Med 16: 
331–344.
19. Pavia M, Bianco A, Pileggi C, Angelillo IF 
(2003) Meta-analysis of residential exposure to 
radon gas and lung cancer. Bull World Health 
Organ 81: 732–738.
20. National Academy of Sciences (1999) Health 
effects of exposure to radon. BEIR VI. 
Washington (District of Columbia): National 
Academy Press. 516 p.
21. Health Canada (1996) Guidelines for Canadian 
drinking water. Ottawa (Canada): Minister 
of Supply and Services Canada. Available: 
http:⁄⁄xnet.rrc.mb.ca⁄rcharney⁄
water%20quality.pdf. Accessed 3 September 
2005.
22. Villanueva CM, Cantor KP, Cordier S, Jaakkola 
JJ, King WD, et al. (2004) Disinfection 
byproducts and bladder cancer: A pooled 
analysis. Epidemiology 15: 357–367.
23. Lanphear BP, Vorhees CV, Bellinger DC 
(2005) Protecting children from environmental 
toxins. PLoS Med 2: e61. DOI: 10.1371⁄journal.
pmed.0020061
December 2005  |  Volume 2  |  Issue 12  |  e350